Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ACADIA Pharmaceuticals Inc. - Common Stock
(NQ:
ACAD
)
21.74
-0.83 (-3.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ACADIA Pharmaceuticals Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
18
19
Next >
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
August 30, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
2 Supercharged Growth Stocks Billionaires Can't Stop Buying
↗
August 28, 2023
A top hedge fund has been steadily buying these two growth stocks in 2023.
Via
The Motley Fool
Analyst Ratings for ACADIA Pharmaceuticals
↗
August 22, 2023
Via
Benzinga
Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?
↗
August 22, 2023
This biotech stock has been on fire in 2023.
Via
The Motley Fool
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street
↗
August 16, 2023
This small-cap biotech might be a hidden gem.
Via
The Motley Fool
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 14, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Analyst Expectations for ACADIA Pharmaceuticals's Future
↗
August 03, 2023
Via
Benzinga
ACADIA Pharmaceuticals's Earnings: A Preview
↗
August 01, 2023
Via
Benzinga
Why Acadia Pharmaceuticals Stock Is Soaring Today
↗
July 14, 2023
Investors are cheering Acadia's latest news.
Via
The Motley Fool
JP Morgan Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know
↗
August 07, 2023
Via
Benzinga
Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview
August 02, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Appoints Kevin R. Oliver, Ph.D., as Senior Vice President, Chief Business Officer
July 24, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Where ACADIA Pharmaceuticals Stands With Analysts
↗
July 11, 2023
Via
Benzinga
Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 2, 2023
July 19, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals: A Mid-Cap Biotech Making Large Moves
July 18, 2023
Acadia may experience a profit-taking pullback near-term but the recent high volume gapper and promising pipeline developments bode well for long-term uptrend.
Via
MarketBeat
Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
↗
July 14, 2023
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Friday. The Dow traded up 0.30% to 34,498.91 while the NASDAQ fell 0.36% to 14,087. The S&P...
Via
Benzinga
Reassuring Market Adoption of Daybue Fuels Acadia's Strategic Advancements, Analysts Boost Price Targets
↗
July 14, 2023
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American
Via
Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
July 14, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
Via
Benzinga
Crude Oil Down 2%; Citigroup Profit Tops Estimates
↗
July 14, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Friday. The Dow traded up 0.31% to 34,501.62 while the NASDAQ rose 0.36% to 14,188.86. The S&P 500, also...
Via
Benzinga
Acadia's Newest Drug Just Obliterated Sales Expectations; Shares Hit Two-Year High
↗
July 14, 2023
The company also expanded its commercial rights to the drug and added another to its line-up.
Via
Investor's Business Daily
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
↗
July 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Are Acadia Pharmaceuticals Shares Trading Higher Today?
↗
July 14, 2023
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) shares are trading higher after the company expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
↗
July 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.
Via
Benzinga
Microsoft To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Friday
↗
July 14, 2023
Keybanc boosted the price target for Spotify Technology S.A. (NYSE: SPOT) from $180 to $205. Keybanc analyst Justin Patterson maintained an Overweight rating. Spotify shares rose 0.9% to $172.68 in...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
July 14, 2023
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Why These 2 Biotech Stocks Made Big Moves Late Thursday
↗
July 13, 2023
Markets kept powering higher on the day.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 13, 2023
Via
Benzinga
Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome
July 13, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
June 29, 2023
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
